Healthcare -
Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - LONG-TERM INVESTMENTS
Long-term Investments KYMR - Kymera Therapeutics, Inc.
61.4 M
LAST VALUE
-29.95%
2 YEAR CAGR
214.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR